Yongshun Biotech announced that the company held an annual shareholders' meeting on May 22, 2026 to review and approve the repurchase and cancellation of 50,000 restricted shares that an incentive recipient has been granted but whose sales restrictions have not yet been lifted. The repurchase price is RMB 4.1 per share, and the total repurchase amount is RMB 205,000. The company repurchased a total of 50,000 shares through a special securities account for share repurchase, accounting for 0.02% of the company's total share capital before the repurchase. On July 23, 2026, the Beijing branch of China Securities Registration and Settlement Co., Ltd. completed the cancellation procedure for 50,000 shares repurchased. After the cancellation was completed, the total number of shares of the company was reduced from 273 million shares to 273 million shares.

Yongshun Biotech announced that the company held an annual shareholders' meeting on May 22, 2026 to review and approve the repurchase and cancellation of 50,000 restricted shares that an incentive recipient has been granted but whose sales restrictions have not yet been lifted. The repurchase price is RMB 4.1 per share, and the total repurchase amount is RMB 205,000. The company repurchased a total of 50,000 shares through a special securities account for share repurchase, accounting for 0.02% of the company's total share capital before the repurchase. On July 23, 2026, the Beijing branch of China Securities Registration and Settlement Co., Ltd. completed the cancellation procedure for 50,000 shares repurchased. After the cancellation was completed, the total number of shares of the company was reduced from 273 million shares to 273 million shares.